Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants

被引:1
|
作者
Anabrees, Jasim [1 ]
AlFaleh, Khalid [2 ]
机构
[1] Arrayan Hosp, Dr Sulaiman Al Habib Med Grp, Riyadh 11635, Saudi Arabia
[2] King Saud Univ, Dept Pediat, Div Neonatol, Riyadh, Saudi Arabia
基金
美国国家卫生研究院;
关键词
PATENT DUCTUS-ARTERIOSUS; BRONCHOPULMONARY DYSPLASIA; NECROTIZING ENTEROCOLITIS; OUTCOMES; RISK; TRIAL; HEMORRHAGE; VALIDITY; CHILDREN; LIFE;
D O I
10.1002/14651858.CD007604.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Although survival of extremely low birth weight (ELBW) infants has dramatically improved over the last decades, the rate of bronchopulmonary dysplasia (BPD) has not changed. The use of indomethacin prophylaxis in ELBW infants results in improved short-term outcomes with no effect on long-term outcomes. The addition of fluid restriction to the indomethacin prophylaxis policy could result in a reduction of BPD and improve long-term survival without neurosensory impairment at eighteen months corrected age. Objectives To determine the effect of a policy of fluid restriction compared with a policy of no fluid restriction on morbidity and mortality in ELBW infants receiving indomethacin prophylaxis. Search strategy We used the standard search strategy for the Cochrane Neonatal Review Group (CNRG). This included searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 1), MEDLINE (1966 to December 2010), and EMBASE (1980 to December 2010). Additional searches included conference proceedings, references in articles and unpublished data. Selection criteria We planned to include all randomized or quasi-randomized trials that compared fluid restriction and indomethacin prophylaxis versus indomethacin prophylaxis alone in ELBW infants. Data collection and analysis If we had identified any eligible studies, we would have assessed the methodological quality of the trials using the standard methods of the CNRG. We planned to use Review Manager 5 software for statistical analysis. Main results We did not identify any eligible trials. Authors' conclusions We found no randomized controlled trials to investigate the possible interaction between fluid restriction and indomethacin prophylaxis versus indomethacin prophylaxis alone in ELBW infants. A well-designed randomized trial is needed to address this question.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Fluid Restriction and Prophylactic Indomethacin in Extremely Low Birth Weight Infants
    Anabrees, Jasim A.
    Aifaleh, Khalid M.
    JOURNAL OF CLINICAL NEONATOLOGY, 2012, 1 (01) : 1 - 5
  • [2] Prophylactic Indomethacin and Intestinal Perforation in Extremely Low Birth Weight Infants
    Kelleher, John
    Salas, Ariel A.
    Bhat, Ramachandra
    Ambalavanan, Namasivayam
    Saha, Shampa
    Stoll, Barbara J.
    Bell, Edward F.
    Walsh, Michele C.
    Laptook, Abbot R.
    Sanchez, Pablo J.
    Shankaran, Seetha
    VanMeurs, Krisa P.
    Hale, Ellen C.
    Newman, Nancy S.
    Ball, M. Bethany
    Das, Abhik
    Higgins, Rosemary D.
    Peralta-Carcelen, Myriam
    Carlo, Waldemar A.
    PEDIATRICS, 2014, 134 (05) : E1369 - E1377
  • [3] Prophylactic indomethacin and intestinal perforation in the extremely low birth weight
    Janvier, A
    Barrington, KJ
    PEDIATRIC RESEARCH, 2002, 51 (04) : 338A - 338A
  • [4] Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants
    Mosalli, R.
    AlFaleh, K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [5] Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
    Fowlie, Peter W.
    Davis, Peter G.
    McGuire, William
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07):
  • [6] Effects of Prophylactic Indomethacin in Extremely Low-Birth-Weight Infants With and Without Adequate Exposure to Antenatal Corticosteroids
    Schmidt, Barbara
    Seshia, Mary
    Shankaran, Seetha
    Mildenhall, Lindsay
    Tyson, Jon
    Lui, Kei
    Fok, Tai
    Roberts, Robin
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2011, 165 (07): : 642 - 646
  • [7] Prophylactic Indomethacin Worsens Short-Term Respiratory Outcomes in Extremely Low-Birth-Weight Infants
    Mondal, Tapas
    Chaudhuri, Dipayan
    Li, Brian
    Shivananda, Sandesh
    Dutta, Sourabh
    AMERICAN JOURNAL OF PERINATOLOGY, 2014, 31 (01) : 61 - 67
  • [8] Effect of Prophylactic Indomethacin in Extremely Low Birth Weight Infants Based on the Predicted Risk of Severe Intraventricular Hemorrhage
    Foglia, Elizabeth E.
    Roberts, Robin S.
    Stoller, Jason Z.
    Davis, Peter G.
    Haslam, Ross
    Schmidt, Barbara
    NEONATOLOGY, 2018, 113 (02) : 183 - 186
  • [9] Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants
    Moya, MP
    Goldberg, RN
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) : 218 - 224
  • [10] Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants
    Yanowitz, TD
    Yao, AC
    Werner, JC
    Pettigrew, KD
    Oh, W
    Stonestreet, BS
    JOURNAL OF PEDIATRICS, 1998, 132 (01): : 28 - 34